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ABSTRACT 
Higher plants are prominent sources for several bioactive chemical constituents (secondary 
metabolites) who include photochemical, flavoring agents, fragrant molecules, and food additives. 
According to WHO estimates, it has been reported that more than 80% of population in 
developing countries prefer these natural bioactive active compounds for their primary health 
requirement. At present, conventional chemotherapy is constrained due to the nonselective 
toxicity to human organs and their usage is limited now a days. In a recent survey, more than 60% 
of cancer patients have been preferring adjuvant phototherapy along with chemotherapy. Thus, 
photochemical are being widely used as anticancer agents to target specific pathological pathways 
underlying cancer with low toxic profiles and side effects. These photochemical are cost-effective 
and easily accessible to the public to treat cancer diseases. These bioactive photochemical are 
meticulously belongs to secondary metabolites such as alkaloids, flavonoids, polyphenols. Among 
them, the flavonoids are polyphenolic substances, which are found in all parts of the plant such as 
flowers, fruits, leaves, roots, seeds, and bark. They possess high medicinal properties like being 
anti-cancer, anti-hypertensive, anti-inflammatory, anti-obesity, anti-malarial, antioxidant agents. 
Quercetin is major flavones associated with a profound antioxidant and medicinal property to 
prevent the oxidation of lipids in vitro and in vivo, and also exhibits direct proapoptotic effects on 
tumor cells. This compound has proven efficacy in targeting several cancer cells of breast, colon, 
prostate, ovarian, and lung tumor in vitro. The present review focuses on the effect of quercetin in 
cancer therapy.   
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1. INTRODUCTION  
 Cancer is a rigorous metabolic syndrome, which also causes death [1-2]. In 2017, USA 
alone reported around 600920 cancer deaths [3]. A normal cell can turn malignant due to genetic 
instabilities and alterations within cells and tissues. These genetic instabilities comprise mutations 
in DNA repair genes (p21, p22, p27, p51, p53 and toolbox for DNA), tumor suppressor genes 
(p53, NF1, NF2, RB and biological breaks), ontogenesis [MYC, RAF, Bcl-2, RAS (biological 
accelerators)] and genes involved in cell growth metabolism. Both external factors and internal 
factors can cause cancer 4]. 
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 Chemotherapy is one of the widely used treatments for cancer [5]. Most of the 
chemotherapeutic agents can destroy cancer cells via the production of reactive oxygen species 
and the induction of either apoptosis or necrosis of tumorouscells[6-9].The purpose of 
chemotherapy is to eradicate the tumor cells, but along with this, diverse ranges of normal cell 
types are also affected leading to many adverse side effects in multiple organ systems and also 
leads to major clinical problems, whereas the toxicity often restricts the effectiveness of 
anticancer agents. Fatigue, nausea, vomiting, malaise, diarrhoea, mucositis, pain, rashes, 
infections, and headaches are most common acute problems (side effects) in cancer patients who 
have undergonecytotoxic therapy [9-12], and also these cytotoxic agents destroys the 
haematopoietic cells, intestinal epithelial cells, and hair matrix keratinocytes [10]. At present, 
conventional chemotherapy is constrained due to the no selective toxicity to human organs and 
their usage is limited now a days. In a recent survey, more than 60% of cancer patients have been 
preferring adjuvant phototherapy along with chemotherapy. 
 Higher plants are prominent sources for several bioactive chemical constituents (secondary 
metabolites) who include photochemical, flavouring agents, fragrant molecules, and food 
additives. In that, photochemical are predominant dietary agents that influence various aspects of 
chemotherapy treatment and their involvement in the cure of cancer patients is enormously 
indicated and needful. Different kinds of photochemical constituents can improve efficiency of 
chemotherapeutic agents, decreases the resistance of chemotherapeutic drugs, lower and alleviate 
the adverse side effects of chemotherapy. According to WHO estimates, it has been reported that 
more than 80% of population in developing countries prefer these natural bioactive active 
compounds for their primary health requirement. Thus, photochemical are being widely used as 
anticancer agents to target specific pathological pathways underlying cancer with low toxic 
profiles and side effects. These photochemical are cost-effective and easily accessible to the 
public to treat cancer. These bioactive photochemical meticulously belong to secondary 
metabolites such as alkaloids, flavonoids, polyphones. 
 Flavonoids are polyphenolic substances which are found in all parts of the plant such as 
flowers, fruits, leaves, roots, seeds, and bark. They are also richly present in foods and plant 
beverages, like, tea, wine and coco [13]; for this reason, they are also termed as dietary 
flavonoids. They are formed in plants, by phenylalanine, tyrosine and malonate (phenylproponaid 
pathway). Animals are unable to manufacture flavones nucleus; flavonoids are exclusively present 
in plant kingdom. Flavonoid participate sin several biological activities in microbes, plants and 
animals. Flavonoids are responsible for pigmentation and aroma of flowers, attracting pollinators 
to fruits, thereby resulting in fruit dispersion as well as spore germination. It also aids the growth 
and development of seedlings. In animals, they have huge amount of medicinal properties like 
being anti-cancer, anti-hypertensive, anti-inflammatory, anti-obesity, anti-malarial, 
hepato‐protective, and antioxidant agents [14]. Flavonoids are sub grouped into several classes 
that includes flavones, flavonones, and flavones, is flavones, flavones and anthocyanins. 
 In flavonoids, flavones are an important sub class, which contains ketene group in their 
structure. The flavones are originator molecules of proanthocyanins. Quercetin, kaempferol, 
myricetin and fisting are the important flavones in flavonoid group. The rich source of flavones 
includes onions, kale, lettuce, tomatoes, apples, grapes and berries. These compounds have high 
medicinal properties such as being antioxidant, and anticancer. 
 
QUERCETIN 
 Quercetin, (3, 3’, 4’, 5, 7-pentahydroxyl-flavone) (Fig. 1) is a major flavonol found in 
various fruits and vegetables (Table 1) such as onions, apples, chokeberries, cranberries, and 
lingonberries [15] and also associated with a profound antioxidant and medicinal property to 
prevent the oxidation of lipids in vitro and in vivo, and also exhibits direct proapoptotic effects on 
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tumor cells. This compound has proven efficacy in targeting several cancer cells of breast, colon, 
prostate, ovarian, and lung tumor in vitro[16]. 
 
 
 
 
 
 
 
 
 
Fig-1: 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one (Baghelet al., 2012) 
 
Table 1. Quercetin Content in Selected Foods (Baghelet al., 2012) 
Food Source Quercetin Content (mg/100g) 
Apple with skin 
Broccoli, Raw 
Raw Onions 
Spinach, raw 
Black Tea Leaves, dry 
Green Tea Leaves, dry 
Red Wine 
4.42 
3.21 
13.27 
4.28 
204.66 
255.55 
0.84 
 
 
QUERCETIN AND ANTI CANCER EFFECT  
In Vitro Studies of Quercetin 
 In vitro studies shows that quercetin has anticancer activity in different cell lines and 
tumor cells, including glioma (U138MG, Braganholet al., 2006 [17]); osteosarcoma (MTX300, 
Xieet al.,2010 [18]);cervical cancer (HeLa, VidyaPriyadarsiniet al.,2010 [19]);  prostatecancer 
(CWR22Rv1, Hsieh andWu,2009 [20]); breast cancer (MDA-MB-453, Choi etal., 2008 [21]); 
myeloid leukaemia (Duraj etal.,2005 [22]); Anti proliferative effect has also been reported at the 
dosage range from 3 to 50 mMin vitro (Lamson and Brig all, 2000; Gibellinietal., 2011[23-24). 
Recent report shows that nanoqurecetin enhances the apoptosis and mRNA expression levels in 
Michigan Cancer Foundation7 (MCF‐7) breast cancer cells. Quercetin was found to sensitize 
MCF‐7 cells to doxorubicin (Dox) and reduce cellular NAD(P)H quinone oxidoreductase 1 and 
multidrug resistant protein 1 gene expression levels [25-26].Quercetin has exhibited the inhibitory 
effect on MCF‐7 and MDA‐MB‐231 human breast cancer cell lines through multiple mechanisms 
such as up‐regulation of miR‐146a expression, induction of apoptosis, activation of caspase‐3 and 
mitochondrial‐dependent pathways, and down‐regulation of the expression of epidermal growth 
factor receptor (EGFR) [27]. In MCF‐7 and MDA‐MB‐231 breast cancer cell lines, gold nano 
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particles conjugated quercetin (AuNPs‐Qu‐5) inhibited cell proliferation through induction of 
apoptosis and suppresses EGFR signalling. In CT26 cells, quercetin inhibits the survival and 
metastatic ability [28]. Quercetin extensively prevents the proliferation of human colon cancer in 
CACO‐2 and SW‐ 620 cells by suppressing the NF‐κB pathway, down‐regulation of 
Bcelllymphoma 2, and up‐regulation of Bax [29]. In H460 cell lines, quercetin inhibits the cell 
production and enhanced sub‐G1 and apoptosis despite of p53 [30]. 
Table2. In vitro anticancer effects of quercetin [31] 
Cell lines Effects Mechanisms References 
MCF-7, HCC1937, 
SK-Br3, 4T1, MDA-
MB-231 
Induced apoptosis 
 
↓Bcl-2, ↓Bax expression, 
↓Her-2, 
inhibition of PI3K-Akt 
pathway 
Duo et al., 2012 
MIA PaCa-2, BxPC-
3 
Inhibited proliferation 
↓Her-2, regulation of 
Wnt/β catenin 
Kim et al., 2013 
CX-1, SW480, 
HT-29, HCT116 
Inhibited proliferation 
↓HIF-1k, regulation of 
Wnt/-catenin 
Shan et al., 2009 
HepG2 Inhibited proliferation ↓PI3K, ↓PKC 
Mauryaet al., 
2015 
A549 Inhibited cell growth ↓cdk1, ↓cyclin B Yehet al., 2009 
 
In Vivo Studies of Quercetin 
 Invivo study shows that oral administration of quercetin can prevent induced 
carcinogenesis, particularly in the colon (Murakami et al., 2008) [32], and also inhibit the growth, 
invasion, and metastatic potential (Caltagironeet al., 2000) [33]. In experimental animal models, 
quercetin that was administered through the dietinhibited the initiation and growth of tumor (Yang 
etal.,2001) [34]. In Sprague–Dawley rats, silver nanoparticle‐based quercetin caused a significant 
reduction in the expression of various proteins including vimentin, Snail, N‐cadherin, Twist, Slug, 
matrix metalloproteinase‐2 (MMP‐2), MMP‐9, vascular endothelial growth factor receptor 2 
(VEGFR2), p‐EGFR, protein kinase B (Akt), phosphoinositide 3‐kinase (PI3K), and glycogen 
synthase kinase 3 beta (p‐GSK3β) and enhanced E‐cadherin protein expression in 7, 
12‐dimethylbenz[a]anthracene‐induced mammary carcinoma [28, 35]. Quercetin can suppress 
colorectal lung metastasis in the mouse model, and may be an effective therapeutic agent for the 
treatment of metastatic colorectal cancer [36]. Treatment with quercetin at a dose of 50 mg/kg in 
mice showed a protective effect on cisplatin‐ induced DNA damage in normal cells, without 
interfering with the antitumor efficacy of the combined treatment. These results suggest that 
quercetin can protect the blood, liver, and kidney cells of mice against HIPEC‐induced injury and 
can increase survival of mice by improving the antitumor adaptive immunity with hyperthermia 
[37]. 10g quercetin/kg dose of quercetin administered to rats for 11weeks, the results show that 
physiological changes in rat awelessdownregulates the potential monogenic MAPK signalling in 
vivo [38]. 
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Table 3.  In vitro anticancer effects of quercetin [31] 
Animal 
models 
Effects Mechanisms Dose Duration References 
FemaleCF1 
mice 
Retarded 
tumor 
growth 
↓PCNA; 
↓mmu-miR-205-
5P 
8 g/kg/day 
(diet) 
42 days Deschneret al., 
1991 
Male F344 
rats 
 
Inhibited 
tumor 
growth 
 
↓EphA2; ↓PI3K; 
↓MMP-2; 
↓MMP-9 
100 mg/kg 
(i.p.) 
18 days Dihalet al., 
2006 
Male F344 
rats 
 
Suppressed 
tumor growth 
↓ACF 25 mg/kg 
(i.p.) 
28 days Dihalet al., 
2006 
Male Swiss 
mice 
 
Inhibited 
tumor 
nodule 
formation 
↓AD 6 mg/kg 
(i.p.) 
 
2 times/ 
week 21 days 
Khandujaet al., 
1999 
Female 
Sprague-
Dawley 
Rats 
Reduced 
tumor 
volume 
↓ADC 17.5 
mg/kg 
(i.v.) 
 
2 times/ 
week for 24 
days 
Verma et al., 
1988 
(i.p., intraperitoneal; i.v., intravenous) 
 
MAJOR MOLECULAR MECHANISMS OF ACTION OF QUERCETIN 
Mutant P53 Protein - Down Regulation 
 In humans, mutations of p53 are the most common genetic abnormalities that lead to 
cancer [39]. Quercetin induces p53 activation resulting in up regulation of Bax and down 
regulation of Bcl‐2 in tumor cells (Fig.:2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 Anticancer role of quercetin- modulating the mitochondrial apoptotic pathways. (Ruafet al., 2018; Khan 
et al., 2016) 
 
Krishnagowdu Saravanan et al. / International Research Journal of Multidisciplinary Technovation /2019, 1(6), 135-143 
This leads to caspase activation and ultimately apoptotic cell[31, 40].Low concentrations of 
quercetin (248 µM) showed reduction and down regulated expression of mutant p53 protein in 
human breast cancer cell lines [41]. In cell cycle, G2-M phase was arrested and expression of p53 
was inhibited [42]. 
 
G1 and G2 PHASE ARREST 
 The p53 gene is the major control point of G1 checkpoint. It is the major cellular 
proliferation control site. Quercetin leads to apoptosis of MCF‐7 and MDA‐MB‐231 breast cancer 
cell lines and along with G1 phase arrest, which significantly suppressed the expression of Twist, 
CyclinD1, p21, and phospho p38 mitogen‐activated protein kinases (p38MAPKs) and also 
effectively controlled the expression of Twist, which induces apoptosis in MCF‐7 cells due to p16 
and p21. These results recommend that quercetin induce apoptosis in cancer cells via suppression 
of twist through p38MAPK [43, 44]. In 70 µM concentration of quercetin, human leukemic T-
cells were arrested at the late G1 phase whereas G1 phase of cell cycle were arrested in gastric 
cancer cells, thereby decrease in DNA replication [45, 46]. 8‐C‐(E‐phenylethenyl) quercetin, a 
novel quercetin derivative, triggers G2 phase arrest in colon cancer cells and suppresses 
proliferation, and also induces autophagiccell death through ERK stimulation. 
 
CONCLUSIONS AND FUTURE PROSPECTIVES 
 Quercetin (flavonol) is a major dietary flavonoid, which has ahigh quality of anticancer 
activity. Quercetin is safe with no reported toxicity when applied for the treatment of human 
cancer. Numerous in vitro and in vivoexperiments shows that quercetin may be effective in 
treatment of various types of cancer and it may be combined with other anticancer drugs to reduce 
their doses and subsequently their side effects.Furthermore, the production of this potent bioactive 
compound can be improved by tissue culture works such as hairy root culture and cell suspension 
culture systems. These systems can be employed in order to produce this compound in large 
quantities.  
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